Evaluation of microglial state using positron emission tomography (PET) imaging with radioligands that bind to the 18 kDa translocator protein (TSPO) found that people with MS with heightened microglial density in NAWM were more likely to experience clinical progression in the absence of new relapses or new MS lesions [189]. This evidence concerns the gene TSPO and myeloid sarcoma.